Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Annoviant logo — Innovations for healthier lives™

Annoviant

Innovations for healthier lives™

Founded 2018 United States Alpharetta, United States 8 employees Grant Total: $4.84M Health Care, Medical Devices

General Information

Company Name Annoviant
Founded Year 2018
Location United States Alpharetta, United States
Employees 8
Industries Health Care, Medical Devices
Funding Stage Grant
Social

BounceWatch is an independent company data service, not affiliated with Annoviant. To contact Annoviant, visit annoviant.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

About Annoviant

Annoviant is a health care startup with the slogan "Innovations for healthier lives™." Founded in 2018 and headquartered in the United States, Annoviant is committed to saving lives by addressing healthcare's most significant challenges. The company is currently focused on the development of medical technologies with a specific interest in cardiovascular applications. Their breakthrough technology, TxGuard™, designed to grow with congenital heart disease patients, has garnered significant attention. Most recently, Annoviant secured a $2.99M grant investment on April 16, 2024, from the National Institutes of Health. This investment underpins Annoviant's potential and the promise of their innovative medical technologies. These developments position Annoviant as a compelling player in the health tech industry, with the potential to significantly impact the future of healthcare.

Taxonomy: cardiovascular health, congenital heart disease, innovation, healthcare challenges, medical device, TxGuard technology, lifesaving technology, patient-focused technology

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Grant $2.99M 1
National Institutes of Health
16 Apr 2024
Grant $1.85M 1
National Institutes of Health
04 Oct 2021

Annoviant Alternatives & Competitors

View All Alternatives
Annoviant vs
Element Science, Inc.
Element Science, Inc. United States

Delivering more tomorrows.

Series C
83 employees
Biotechnology, Hardware
Annoviant vs
Novostia
Novostia Switzerland

Heart valves for life, for patients of any age, including children

15 employees
Health Care, Medical Devices
Annoviant vs
Puzzle Medical Devices Inc.
Puzzle Medical Devices Inc. Canada

Presenting the ModulHeart. Low-risk heart support for patients with advanced heart failure

Series A
32 employees
Health Care, Medical Devices
View all alternatives

FAQ About Annoviant

Innovations for healthier lives™
Annoviant was founded in 2018.
Annoviant is headquartered in Alpharetta, United States.
Annoviant operates in Health Care and Medical Devices. Its work centres on cardiovascular health, congenital heart disease, innovation and healthcare challenges.
Annoviant has approximately 8 employees.
Annoviant has completed 2 funding rounds, raising a total of $4.84M. The latest funding stage is Grant.
Top alternatives and competitors to Annoviant include Element Science, Inc., Novostia, Puzzle Medical Devices Inc., Walkky, Ventripoint Diagnostics Ltd.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Annoviant and Element Science, Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Annoviant, https://bouncewatch.com/company/annoviant, updated 28 October 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes